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Abstract: - The world is now facing an unprecedented crisis due to the novel coronavirus. The disease has spread around 210 
countries and territories around the globe and infected (confirmed) more than twelve million people (09/07/2020). The global death 
rate due to coronavirus was around 584k, respectively. This intense situation emerges the necessity of drug discovery and 
vaccination against SARS-COV2. The total (cumulative) number of confirmed infected people is 767K until now across India (09 
JUL 2020). Most of the research and newspaper articles focus on the number of infected people over the countries. In the absence 
of a vaccine, the preventive measures of maintaining basic personal hygiene and large-scale social distancing appears to be most 
effective against SARS-COV2 causing infection. The effect of preventing actions and lockdown was observed that the count was 
in control during the lockdown period. Complete unlocking protocols may elevate the possibility of viral spread. A sustained 
lockdown with considerable relaxation is suggested. This article discusses the timeline events and guidance of Indian governance 
on this pandemic 2020. Additionally, it also covers the graphical growth curvature of Morbidity and Mortality rate, centre’s 
accomplishments, economical inspection, and exponential growth. 
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I. INTRODUCTION 
The family Coronaviridae comprises a group of large, single, 
plus‐stranded RNA viruses isolated from several species. It is 
previously known to cause the common cold and diarrheal 
illnesses in humans. Recently, a new coronavirus (2019‐
nCoV) has emerged in the region of Wuhan (China) as a cause 
of severe respiratory infection in humans. The novel 
coronavirus originated from bats, and the spike glycoprotein's 
evolutionary changes provide the transmission chain to the 
Homo Sapiens. The infected host will develop acute throat 
soreness, dry cough, and fever. Severe symptoms are 
shortness of breathing, chest angina, loss of movement. Many 
countries involved in the race of drug discovery for SARS-
COV2. Experts expressed concern about the spread of 
COVID-19 and its potential to cause more than 1.7 billion 
infections and 7.6 million deaths in South Asia alone if no 
actions were taken. India, the world's second-most populous 
country and the largest in South Asia with a population of 
nearly 1.4 billion, is at risk of having a high share of these 
infections. Indian government regulates this viral outbreak by 
implementing lockdown, awareness, social distancing, 
financial support, quarantine the infected people, and 
hospitalization. Despite the government's efforts to contain 
the disease in the affected districts only, it has so far hit 558 
out of 640 districts. 
The consequences so far reached is not only due to population 
but also because of other reasons, including challenges in 
practicing social distancing, non-universal access to water, 
soap, and sanitizer. Physicians and nursing staffs working in 
the COVID-19 ward also suffer due to inadequate Personal 
Protective Equipment (PPE). The vital aspect of the epidemic 
that affects a community spread of the disease is the number 
of asymptomatic cases in the population. As per Government 
of India data more than 80% of confirmed cases in India are 
asymptomatic, making the population vulnerable to 
community spread of the virus. Coronavirus outbreak is a 
situation that could not be foreseen. Although Medicare 
(medical facilities and health policies) in India is gaining its 
momentum, and health care has become at par with 
technologies, the country is facing a hard time in battling 
COVID-19. The government developed 'Aarogya Setu,' a 
mobile application to connect essential health service. This 
app helps to reach out and use information regarding COVID-
19 risks, best practices, and advisories. This paper attempts to 
explain the concept of analysis in the management of the 
epidemic in India. 
II. LITERATURE SURVEY  
Indian governance on SARS-COV2 viral outbreak– Timeline: 
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30 January 2020 - India confirms its first coronavirus case. 
(reid, 2020): 
The Ministry of Health and Family Welfare said the country’s 
first case was a patient in Kerala, a southwestern coastal state. 
The Ministry said in the statement that the patient is a student 
at Wuhan University in China and has been isolated in a 
hospital. 
02 February 2020 - India temporarily suspends the e-visa 
facility for Chinese and foreigners residing in China.  (The 
Times Of India, 2020) 
India temporarily suspended e-visa facility for Chinese 
travellers and foreigners residing in China in the view of 
virulent novel coronavirus that has killed more than 300 
people, infected 14562 others and spread to 25 countries 
including India, U.S and U.K. 
03 February 2020 - Kerala's third coronavirus case 
confirmed in Kasaragod. (Smitha N, 2020) 
India’s third case of coronavirus has been reported on 
February 3, 2020 from Kerala, again. Two Wuhan University 
students who returned recently from China are said to be 
infected with the novel coronavirus and are treated at 
government medical college hospitals. The medical student, a 
batchmate of the two infected students, has tested positive for 
the viral infection, said health minister K.K Shylaja in the 
State Assembly. 
18 February 2020 - Indian industries steps to deal with impact 
of COVID-19 soon, says Nirmala Sitharaman (The Hindu, 
2020) 
Ms. Sitharaman downplayed fears of any immediate price rise 
of medicines or other products, saying there were no reports 
of immediate shortages. However, official sources present at 
the meeting said most sectors have three to four weeks of raw 
materials available, adding that the longer-term impact is still 
uncertain. 
11 March 2020 – World Health Organisation declares 
COVID-19 a Pandemic (Cucinotta D, 2020)  
On March 11, 2020, the World Health Organisation (WHO) 
declared the novel coronavirus (COVID-19) outbreak a global 
pandemic. WHO Director-General, Dr. Tedros Adhanom 
Ghebreyesus, noted that WHO is deeply concerned by the 
alarming levels of spread and severity, and by the alarming 
levels of inaction. He also added that ‘pandemic’ is not a word 
to be used lightly or carelessly. If misused, it can cause 
unreasonable fear or unjustified acceptance that the fight is 
over, leading to unnecessary suffering and death. 
12 March 2020 – Karnataka announces India’s first 
coronavirus death (The Economic Times, 2020) 
A 76-year-old man who died had tested positive for the novel 
coronavirus, an Indian state health minister reported on 
Thursday, 12th March, 2020, marking the country's first 
fatality from the global pandemic. 
13 March 2020 – The Punjab, Chhattisgarh and Manipur 
governments declared schools and colleges closed until 
March 31   
The Punjab and Chhattisgarh governments declared all 
schools and colleges closed till March 31. Manipur 
government announced that all schools in the state, where 
examination are not being held would remain closed till 
March 31. 
17 March 2020 - India still in Stage 2, says Indian Council of 
Medical Research (ICMR) (Times Now News, 2020) 
India continues to be in stage-2 and not stage-3 of coronavirus 
pandemic, the ICMR said on Tuesday, 17 March, 2020. Dr 
Balram Bhargava, director general of ICMR said that 72 
laboratories are currently testing the virus in the country, 
while 49 others will be added by end of this week. However, 
he added that it would be too early to say that we have 
contained the virus. 
22 March 2020 - Modi announces ‘Janata Curfew’, urges for 
resolve, and restraint to fight coronavirus (Chandna, Himani., 
Basu, Mohana, 2020) 
The prime minister, in a televised address to the nation, 
announced a ‘Janata Curfew’ from 7 am to 9 pm on Sunday, 
22 March, to stop the spread of coronavirus that has already 
claimed four lives in the country and infected at least 169 
others. “Under the ‘Janata Curfew’ no one will go out of their 
houses. It will also prepare us for the forthcoming days,” said 
PM Modi, hinting that such isolation drives could be essential 
in future to stop the spread of COVID19. 
24 March 2020 – Prime Minister Modi announces 21-day 
lockdown as COVID-19 toll reaches 12 (Hebbar, 2020) 
As the death toll from COVID-19 rose to 12, Prime Minister 
Narendra Modi announced a 21-day lockdown for the entire 
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country, stating that it was the only way to break the chain of 
infection. He added that the lockdown will be in effect till 
April 14. 
30 March 2020 – Health Ministry declares no community 
transmission yet (Ghosh, 2020) 
Even as the number of coronavirus cases in India crossed 
1,250, the Health Ministry on Monday reiterated that COVID-
19 is still in the local transmission stage in India and that there 
has been “no community transmission yet”. “If there will be a 
community transmission, we will convey it to the community 
through mass media to increase the level of alertness and 
management for COVID-19 at the field level,” said Lav 
Agarwal, Joint Secretary in the Health Ministry. 
03 April 2020 - ICMR recommends antibody test for speedy 
detection of COVID-19 cases (The Hindu, 2020) 
The Indian Council of Medical Research (ICMR) in its 
interim advisory has recommended the use of the rapid 
antibody test in the country’s coronavirus hotspots. The 
decision for the recommendation was taken at an emergency 
meeting of the National Task Force, formed to deal with the 
health crisis. 
05 April 2020 - India stands against COVID-19: Prez Kovind, 
Narendra Modi, Amit Shah, Rajnath Singh ignite ‘diyas’ of 
hope (Kapoor, 2020) 
As India lit up to mark Prime Minister's appeal of lighting 
candles, diyas and flashlights at 9 pm for nine minutes, several 
prominent political leaders joined the nationwide exercise by 
switching off the lights at their residences. President Ram 
Nath Kovind also participated in this national exercise. 
President Kovind showed the collective solidarity and 
positivity of all the countrymen by lighting a candle at 9 pm 
along with his first lady and other family members. 
14 April 2020 – Prime Minister Narendra Modi extended the 
lockdown till May 3, 2020 (Prabhu, 2020) 
Prime Minister Narendra Modi has extended the lockdown till 
May 3 to control the spread of coronavirus in India and said 
the restrictions could be reviewed for the least affected parts 
of the country on April 20. “Till April 20, each district, each 
state will be monitored closely to see whether the lockdown 
is being followed. Then we can decide on relaxing the 
restrictions,” said the Prime Minister. 
28 April 2020 - No more use of rapid test kits; ICMR issues 
advisory to States and UT’s (Financial Express, 2020) 
 Indian Council of Medical Research in its advisory 
recommended to stop the usage of rapid test kits in India, an 
advisory issued by ICMR to Chief Secretaries of all States and 
UTs advocates that RT-PCR throat/nasal swab test is the best 
use for COVID-19 diagnosis. 
01 May 2020 – Ministry of Home Affairs permitted special 
trains for the stranded (Jain, 2020) 
The Home Ministry allowed the movement of migrant 
workers as well as stranded students, pilgrims, tourist and 
others by ‘special shramik’ trains, with due adherence to 
social distancing norms at railway station, platforms and 
inside the trains. 
02 May 2020 - India extends limited lockdown till May 17 
(India Today, 2020) 
The Ministry of Home Affairs extended the lockdown for two 
weeks while allowing different sets of relaxations in red, 
orange and green zones. The new guidelines aim at allowing 
India to exit from lockdown in a staggered manner while 
reopening the economy. 
07 May 2020 - ICMR partners with India Post for delivery of 
COVID-19 testing kits (The Economic Times, 2020) 
The Indian Council of Medical Research (ICMR) has joined 
hands with the India Post for the delivery of COVID kits from 
its 16 regional depots to 200 additional labs designated for 
coronavirus tests across the country, reported ANI. “While 
continuing to deliver money to the doorsteps through Aadhaar 
enabled payment system, the India Post has entered into a tie-
up with ICMR on April 20 this year for the delivery of its 
COVID kits from its 16 regional depots to the 200 additional 
laboratories designated for COVID testing across the length 
and breadth of the country,” said an official statement. 
17 May 2020 - Nationwide lockdown extended till May 31, 
with considerable relaxations (The Economic Times, 2020) 
The centre extended the nationwide lockdown till May 31. 
The fourth phase of the lockdown was commenced on 17th 
May 2020. The government has allowed considerable 
relaxations in this round of lockdown. Inter-state movement 
of vehicles, buses have been allowed with states and Union 
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27 May 2020 - ICMR has approved 624 laboratories across 
India to conduct COVID-19 tests (Fresherslive, 2020) 
ICMR was continuously scaling up its testing facilities for the 
COVID-19 by approving government and private 
laboratories. So far, ICMR has approved a total of 624 
laboratories across India to conduct the tests for COVID-19 
including 435 government laboratories and 189 private 
laboratories. 
31 May 2020 - India's recovery rate improved to 47.76% 
(Times Of India, 2020) 
The recovery rate of coronavirus patients has increased to 
47.76 percent, said the Union Ministry of Health and Family 
Welfare. "In the last 24 hours, 4,614 patients were cured. A 
cumulative total of 86,983 people has been cured. This takes 
the total recovery rate to 47.76 per cent," read an official 
statement issued by the ministry. 
14 June 2020- Remdesivir, Tocilizumab and CPT included in 
revised protocols for COVID-19 clinical management (EP 
News Bureau, 2020) 
ICMR has revised the protocol for clinical management 
of COVID-19. It has allowed the use of Remdesivir, 
Tocilizumab and Convalescent Plasma Therapy (CPT) on 
certain groups of patients. The document says, “Remdesivir” 
may be considered in patients with moderate disease (those on 
oxygen), Tocilizumab (Off Label) may be considered in 
patients with moderate disease 
with progressively increasing oxygen requirements and in 
mechanically ventilated patients not improving despite the 
use of steroids. Long term safety data in COVID-19 remains 
largely unknown. Convalescent plasma (Off Label) may be 
considered in patients with moderate disease who are not 
improving (oxygen requirement is progressively increasing) 
despite the use of steroids.” 
19 June 2020 - Over 7,000 tests using rapid antigen 
methodology conducted on first day in Delhi: ICMR (The 
Hindu, 2020) 
In a statement, the ICMR said it has facilitated and approved 
rapid-antigen test for COVID-19 that gives results in 30 
minutes in order to fast track reliable and affordable testing 
essentially in high containment areas. Rapid antigen testing 
was launched in Delhi and on the first day, over 7,000 tests 
were conducted, it said. 
25 June 2020 - Over 1.63 lakh stranded Jammu & Kashmir 
residents evacuated from rest of India (The Hindu, 2020) 
Over 1.63 lakh residents of Jammu and Kashmir stranded in 
various places across India due to the coronavirus lockdown 
have been evacuated, officials said. The administration has 
evacuated about 1,63,217 Jammu and Kashmir residents, 
stranded in other parts of the country due to the COVID-19 
lockdown, through special trains and buses till date amid strict 
observance of all necessary guidelines and standard operating 
procedures, they said. 
30 June 2020 - First COVID-19 vaccine clinical trial 
approved in India (European Pharmaceutical Review, 2020) 
India’s first potential COVID-19 vaccine has been given 
approval for phase I and phase II clinical trials. Named 
Covaxin, the vaccine was developed by Bharat Biotech and 
has been granted approval from the Drugs Controller General 
of India (DCGI). Human clinical trials are scheduled to start 
across India in July 2020.Bharat Biotech created Covaxin in 
collaboration with the Indian Council of Medical Research 
(ICMR) and National Institute of Virology (NIV). According 
to the company, the SARS-CoV-2 strain was isolated in NIV, 
Pune and transferred to Bharat Biotech. 
02 July 2020 -  RMRC lab, Assam becomes 4th to isolate 
COVID-19 virus strain in India (Fresherslive, 2020) 
Regional Medical Research Centre (RMRC) located in 
Lahowal in Dibrugarh district of Assam has successfully 
isolated the SARS-CoV-2 virus strain becoming the fourth 
such facility in the country to achieve the feat. Scientists at 
RMRC stated that all strains of SARS-CoV-2 were L-type and 
not S-type, which is slowly disappearing across the world. 
05 July 2020 - Government says COVID-19 vaccine unlikely 
before 2021 after ICMR's August 15 launch deadline, 
backtracks later (India Tv, 2020) 
The Ministry of Science and Technology clarified that none 
of the coronavirus vaccine candidates, including India's 
Covaxin and ZyCov-D, are likely to be ready for public use 
before 2021. "Six Indian companies are working on a 
COVID-19 vaccine. Along with two Indian vaccines, 
Covaxin and ZyCov-D, world over 11 out of 140 vaccine 
candidates are in human trials. None of these are likely to be 
ready for mass use before 2021," the Ministry of Science and 
Technology said in a statement.  
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07 July 2020 - Human trial process starts at Hyderabad's 
NIMS (Live Mint, 2020) 
The much-awaited trial process of India's first possible 
vaccine against COVID-19, Covaxin, has started at the 
Nizam's Institute of Medical Sciences (NIMS). Developed by 
Bharat Biotech, the Covaxin will be tested on over 1,100 
people in two phases. The company had a plan to enrol 375 
participants to test COVID-19 vaccine this month. 
09 July 2020 - Active Covid-19 cases down to 25% in Delhi 
(Times Of India, 2020) 
Delhi recorded 2,033 new cases of Covid-19, taking the total 
count in the state to 1,04,864. The number of fatalities in the 
past 24 hours was reported to be 48. With this, the state’s 
death toll has reached 3,213. As many as 78,199 (75%) of 
total Covid-19 patients reported till date have recovered from 
the disease, the latest data shared by Delhi government 
showed. This includes 3,982 Covid-19 patients who 
recovered in the past 24 hours. 
III. MORBIDITY AND MORTALITY RATE IN INDIA 
Both Morbidity and Mortality rate from COVID-19 infection 
have significant differences across age-groups, infants and 
elderly people get easily affected and mortality increasing 
rapidly with elderly. The morbidity and mortality count 
collected from the Ministry of Health and Family Welfare 
(MOHFW). This research based on secondary sources of data 
and information from various domains to analyse. The 
following graphical data represents a cumulative number of 
SARS-COV2 infected individuals from January 2020 to July 
2020. 
 
Fig.1.1. The Graphical Representation of total number of 
COVID-19 infected cases and death in last 11 days of 
January 2020. 
On 30th January 2020, the first COVID-19 case of India was 
reported in Kerala, among a group of students who arrived in 
the southern state of Kerala from Wuhan, the epicentre of the 
outbreak at that time. (Figure 1.1) 
 
Fig.1.2. The Graphical Representation of total number of COVID-
19 infected cases and death in February 2020 
In the month of February 2020, Total cumulative of 3 patients 
were infected (Figure 1.2). Those three patients from Kerala 
have successfully recovered from the infection as on Friday, 
February 14, 2020. 
 
Fig.1.3. The Graphical Representation of total number of COVID-
19 infected cases and death in March 2020 
As on March 2020, Total number of 50 patients infected 
(confirmed) and zero death were found till march 10. The 
cumulative count of 223 cases and 4 deaths in the 2nd tenth of 
march. In the very end of march, the number was increased to 
1,397 cases and 35 deaths. (Figure 1.3) 
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Fig.1.4. The Graphical Representation of total number of COVID-
19 infected cases and death in April 2020 
The first tenth of April reported 6,761 cases and 206 death 
(confirmed). Even on 13 April, the affected cases are 904 on 
that particular day. The total cumulative number rose to 
17,656 cases and 559 deaths on 20th March. In the very end of 
April, increased number of 33,610 cases and 1,075 deaths 
were reported. (Figure 1.4) 
 
Fig.1.5. The Graphical Representation of total number of COVID-
19 infected cases and death in May 2020 
The number of 62,939 cases and 2,109 deaths were reported 
on May 10th. In 2nd tenth of May, infected rate was 
consecutively increased to 106,750 and 3,303 deaths in 
number. In the very end of May, the cases were rose to 
182,143 and 5,164 deaths. (Figure 1.5) 
 
Fig.1.6. The Graphical Representation of total number of COVID-
19 infected cases and death in June 2020 
The total cumulative of cases and death on 10th June was 
increased to 276,583 and 7,745, respectively. In the second 
tenth of month, the count was found to be 395,048 and 12,948. 
In the very end of the month, the cases and death count rose 
to 566,840 and 16,893. (Figure 1.6) 
 
Fig.1.7. The Graphical Representation of total number of COVID-
19 infected cases and death in July 2020 
The case and death counts increased tremendously and 
reached the peak of 767,296 and 21,129 on 9th July 2020. It is 
necessary to consider that the intensity of this viral infection 
wasn’t ended on last date mentioned. (Figure 1.7) 
IV. EXPONENTIAL GROWTH ANALYSIS 
In Figure (2.1), the morbidity rate curve increased peak in 
number after the implementation of unlocking protocols, was 
observed. The growth rate was controlled in number during 
lockdown period.  
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Fig.2.1. The Graphical Representation of Morbidity rate due to 
COVID-19 infection, up to July 2020 
This pattern indicates that the COVID-19 situation went to 
peak in last 2 months after unlocking Green and Orange zone. 
For the population of 1379 million in India, the rate of 
affected people is 0.05% (767,296 confirmed cases). Reason 
for increasing the cases in India could be because of the 
ineffective lockdown (only first two lockdowns were 
effective), inadequate social distancing, lesser number of 
sample test and relaxing the lockdown policy for various 
industries which is indirectly leading to the spread. Once the 
spread is increased in India, it becomes a challenge as we have 
more cases in population dense cities. Mumbai, Delhi and 
Chennai are the cities affected badly by COVID-19, and the 
population density of those cities are pretty high. The 
mortality rate increase in an exponential manner as number 
reached 21k, so far. (Figure 2.2) 
 
Fig.2.2. The Graphical Representation of Mortality rate due to 
COVID-19 infection, up to July 2020 
This Exponential growth analysis is based on simple 
algebraic expression: 
Y = abx 
 
Where, 
Y = Exponential function 
a = Initial value (in number) 
b = Average growth factor  
x = Expected time period (in number) 
 
Initial count (a) = 767,296 (09/07/2020) 
Growth factor (b) = 1.035 
Expected period (x) = 60 days 
Y = 767,296 * 1.03560 
 = 767,296 * 7.878   
Exponential growth (Y) = 60,44,827 
From the (Table 1), we figured out that the growth factor was 
not exceed above 1.040. The average growth factor was 
calculated on the basis past 21 day’s case count. Exponential 
rate for next 60 days from 09/07/2020 to 07/09/2020 was 
predicted to be 60,44,827 in number. (Figure 2.3) 
 
Figure 2.3 The Graphical Representation of Exponential Morbidity 
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Table.1. - Growth factor value 
V. CONCLUSION  
In India up to 53% of businesses have specified a certain 
degree of impact of shutdowns caused due to COVID-19 on 
operations, as per a FICCI survey in March. By 24 April the 
unemployment rate had increased nearly 19% within a month, 
reaching 26% unemployment across India, according to the 
'Centre for Monitoring Indian Economy. Experts report 
admits that in the fourth quarter [Q4] of this financial year, 
which is January-March of 2020, that is before the 
coronavirus pandemic set in, the GDP growth rate on an 
annual basis had further declined to 3.1%. Around 
140,000,000 (14 crores) Indians lost employment during the 
lockdown. More than 45% households across the nation 
reported an income drop as compared to the previous year. 
Various business such as hotels and airlines cut salaries and 
laid off employees. Different phases of India's lockdown up 
to the "first unlock" on 1 June had varying degrees of the 
opening of the economy. The centre allowed all industries and 
markets to reopen and curfew time changed to 9pm to 5am. 
By mid-June, unemployment levels were back to pre-
lockdown levels. Online sales reached normal level sales by 
June end. On 2nd July 2020, The Times of India reported that 
a number of economic indicators such as the manufacturers 
purchasing manager’s index, goods movement, GST 
collections, electricity usage and rail freight transport showed 
significant improvement as compared to previous months. 
However, until getting the vaccination or therapeutic 
medicines, India need to control the spread with the enhanced 
lockdown and considerable relaxation in the affected areas by 
ensuring the adequate social distancing to mitigate the 
pandemic situation effectively.  It is mandatory for every 
individual of nation should aware, maintain social distancing 
and personal hygiene. In conclusion, the chronological study 
presented in this paper declares Indian government regulated 
this historical viral outbreak in effective manner by curfews, 
closures of educational institutes, restrictions of non-essential 
businesses and restrictions of mass gatherings. The 
contribution of Health Ministry and ICMR is remarkable in 
hospitalization of infected patients and in developing vaccine. 
Exponential growth analysis predicts that the morbidity rate 
will be increased to 0.43% to the total population on 7th 
September 2020. The nation should be follow above the 
suggestion for effective management of this viral infection in 
future. 
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